"10.1371_journal.pone.0023597","plos one","2011-08-10T00:00:00Z","Sonia Chelouah; Caroline Monod-Wissler; Christian Bailly; Jean-Marc Barret; Nicolas Guilbaud; Stéphane Vispé; Emmanuel Käs","Université de Toulouse, UPS, Université Paul Sabatier, Laboratoire de Biologie Moléculaire Eucaryote; Toulouse; France; CNRS, Centre National de la Recherche Scientifique, UMR5099, Laboratoire de Biologie Moléculaire Eucaryote, Toulouse, France; Centre de Recherche en Oncologie Expérimentale, Institut de Recherche Pierre Fabre, Toulouse, France","Conceived and designed the experiments: EK SV NG JMB SC CMW. Performed the experiments: SC CMW SV. Analyzed the data: EK SV CB NG SC CMW. Contributed reagents/materials/analysis tools: CB NG JMB SV. Wrote the paper: EK SV CB NG JMB.","The authors have read the journal's policy and have the following conflicts: Christian Bailly, Jean-Marc Barret, Nicolas Guilbaud and Stéphane Vispé are fulltime employees of Institut de Recherche Pierre Fabre (IRPF), which developed F14512, a patented drug, and conducts its ongoing phase I clinical trials; Research in Emmanuel Käs's lab was funded in part by IRPF, of which EK is neither an employee nor a consultant and is not involved in patents, products in development or marketed products. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2011","08","Sonia Chelouah","SC",7,TRUE,6,3,6,5,TRUE,TRUE,FALSE,0,NA,FALSE
